Search Results - "Lachenal, Nathalie"

Six-Month Response to Delamanid Treatment in MDR TB Patients by Hewison, Cathy, Ferlazzo, Gabriella, Avaliani, Zaza, Hayrapetyan, Armen, Jonckheere, Sylvie, Khaidarkhanova, Zarema, Mohr, Erika, Sinha, Animesh, Skrahina, Alena, Vambe, Debrah, Vasilyeva, Irina, Lachenal, Nathalie, Varaine, Francis

“…Delamanid, recently available for the treatment of multidrug-resistant tuberculosis (MDR TB), has had limited use outside clinical trials. We present the early…”
Get full text

One Step Forward: Successful End-of-Treatment Outcomes of Patients With Drug-Resistant Tuberculosis Who Received Concomitant Bedaquiline and Delamanid in Mumbai, India by Das, Mrinalini, Dalal, Alpa, Laxmeshwar, Chinmay, Ravi, Shilpa, Mamnoon, Fatima, Meneguim, Augusto C, Paryani, Roma, Mathur, Taanya, Singh, Pramila, Mansoor, Homa, Kalon, Stobdan, Hossain, Farah Naz, Lachenal, Nathalie, Coutisson, Sylvine, Ferlazzo, Gabriella, Isaakidis, Petros

“…Abstract Background The Médecins Sans Frontières Clinic in Mumbai, India, has been providing concomitant bedaquiline (BDQ) and delamanid (DLM) in treatment…”
Get full text

Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL by Crocker-Buque, Tim, Lachenal, Nathalie, Narasimooloo, Cindy, Abdrasuliev, Tleubergen, Parpieva, Nargiza, Tigay, Zinaida, Liverko, Irina, Usmanova, Ruzilya, Butabekov, Ilhomjon, Moodliar, Ronelle, Mbenga, Mansa, Rasool, Mohammad, Nyang'wa, Bern-Thomas, Berry, Catherine

Get full text

Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort by Hewison, Catherine, Khan, Uzma, Bastard, Mathieu, Lachenal, Nathalie, Coutisson, Sylvine, Osso, Elna, Ahmed, Saman, Khan, Palwasha, Franke, Molly F, Rich, Michael L, Varaine, Francis, Melikyan, Nara, Seung, Kwonjune J, Adenov, Malik, Adnan, Sana, Danielyan, Narine, Islam, Shirajul, Janmohamed, Aleeza, Karakozian, Hayk, Kamene Kimenye, Maureen, Kirakosyan, Ohanna, Kholikulov, Begimkul, Krisnanda, Aga, Kumsa, Andargachew, Leblanc, Garmaly, Lecca, Leonid, Nkuebe, Mpiti, Mamsa, Shahid, Padayachee, Shrivani, Thit, Phone, Mitnick, Carole D, Huerga, Helena

“…Abstract Background Safety of treatment for multidrug-resistant tuberculosis (MDR/RR-TB) can be an obstacle to treatment completion. Evaluate safety of longer…”
Get full text

Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs by Huerga, Helena, Khan, Uzma, Bastard, Mathieu, Mitnick, Carole D, Lachenal, Nathalie, Khan, Palwasha Y, Seung, Kwonjune J, Melikyan, Nara, Ahmed, Saman, Rich, Michael L, Varaine, Francis, Osso, Elna, Rashitov, Makhmujan, Salahuddin, Naseem, Salia, Gocha, Sánchez, Epifanio, Serobyan, Armine, Rafi Siddiqui, Muhammad, Grium Tefera, Dri, Vetushko, Dmitry, Yeghiazaryan, Lusine, Holtzman, David, Islam, Shirajul, Kumsa, Andargachew, Jacques Leblanc, Gamarly, Leonovich, Olga, Mamsa, Shahid, Manzur-Ul-Alam, Mohammad, Myint, Zaw, Padayachee, Shrivani, Franke, Molly F, Hewison, Catherine

“…Concomitant use of bedaquiline (Bdq) and delamanid (Dlm) for multi-drug/rifampicin resistant tuberculosis (MDR/RR-TB) has raised concerns about a potentially…”
Get full text

Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs by Lotia Farrukh, Ismat, Lachenal, Nathalie, Adenov, Malik M, Ahmed, Saman, Algozhin, Yerkebulan, Coutisson, Sylvine, Garavito, Epifanio Sánchez, Hewison, Catherine, Holtzman, David, Huerga, Helena, Janmohamed, Aleeza, Khan, Palwasha Y, Jacques, Gamarly Leblanc, Lomtadze, Nino, Melikyan, Nara, Mitnick, Carole D, Mussabekova, Gulnaz, Osso, Elna, Perea, Sara, Putri, Fauziah Asnely, Rashidov, Mahmud, Rich, Michael L, Sakhabutdinova, Yekaterina, Seung, Kwonjune J, Stambekova, Assel, Vásquez, Dante Vargas, Franke, Molly F, Khan, Uzma

“…Among 43 pregnant women receiving multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) treatment with bedaquiline and/or delamanid, 98% had…”
Get full text

Oral Cladribine as Add on to IFN β Therapy in Patients with Active Multiple Sclerosis: Results from the Phase II ONWARD Study (P07.099) by Montalban, Xavier, Cohen, Bruce, Leist, Thomas, Moses, Harold, Hamlett, Anthony, Scaramozza, Matthew, Lachenal, Nathalie

“…Abstract only…”
Get full text

Oral Cladribine Delays Time to Conversion to Clinically Definite MS in Patients with a First Demyelinating Event: Top Line Results from the Phase III ORACLE MS Study (P07.114) by Leist, Thomas, Comi, Giancarlo, Cree, Bruce, Coyle, Patricia, Freedman, Mark, Hartung, Hans, Vermersch, Patrick, Orejudos, Amelia, Lachenal, Nathalie, Scaramozza, Matthew

“…Abstract only…”
Get full text

Oral Cladribine Safety Profile in Patients with a First Demyelinating Event: Top Line Results from the Phase III ORACLE MS Study (P01.177) by Leist, Thomas, Comi, Giancarlo, Cree, Bruce, Coyle, Patricia, Freedman, Mark, Hartung, Hans, Vermersch, Patrick, Orejudos, Amelia, Lachenal, Nathalie, Scaramozza, Matthew

“…Abstract only…”
Get full text

Safety and Efficacy of Oral Cladribine in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the 96 Week Phase IIIb Extension Trial to the CLARITY Study (P07.119) by Giovannoni, Gavin, Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Rieckmann, Peter, Soelberg-Sorensen, Per, Vermersch, Patrick, Hamlett, Anthony, Scaramozza, Matthew, Lachenal, Nathalie

“…Abstract only…”
Get full text

Retrieving mutation-specific information for human proteins in UniProt/Swiss-Prot Knowledgebase by Yip, Yum Lina, Lachenal, Nathalie, Pillet, Violaine, Veuthey, Anne-Lise

“…The UniProt/Swiss-Prot Knowledgebase records about 30,500 variants in 5,664 proteins (Release 52.2). Most of these variants are manually curated single amino…”
Get more information